PETS Company Profile and Key Details

Q: Who are the executives of PETS?

Wendy ZalaiCorporation Controller & Corp. Sec.Mr. Daniel Job PingreeChief Marketing OfficerMs. Jacqueline SmithVice President of PeopleMr. Matthew N. HulettChief Executive Officer, Pres & DirectorMr. Bruce S. RosenbloomTreasurerMs. Christine ChambersChief Financial Officer, Principal Financial Officer, Principal Accounting Officer, Treasurer & Sec.Mr. Mark MoseleyChief Technology & Information OfficerMr. Mathew N. HulettChief Executive Officer, Pres & Director

NASDAQ : PETS

PetMed Express

$2.75

-0.03-1.08%

At Close 4:00 PM

61.13

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

PetMed Express, Inc. (PETS) stock declined over -1.08%, trading at $2.75 on NASDAQ, down from the previous close of $2.78. The stock opened at $2.77, fluctuating between $2.71 and $2.78 in the recent session.

Stock Snapshot

2.78

Prev. Close

58.85M

Market Cap

2.71

Day Low

-0.88

P/E Ratio

-3.11

EPS (TTM)

0.08

Cash Flow per Share

2.77

Open

21.4M

Number of Shares

2.7799

Day High

66.49%

Free Float in %

4.9

Book Value

55.7K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 26, 2026	2.77	2.79	2.71	2.75	57.78K
Feb 25, 2026	2.77	2.84	2.75	2.78	119.03K
Feb 24, 2026	2.88	2.91	2.79	2.81	64.87K
Feb 23, 2026	2.95	2.97	2.83	2.88	106.51K
Feb 20, 2026	3.00	3.06	2.94	2.95	67.63K
Feb 19, 2026	3.06	3.09	3.00	3.01	61.89K
Feb 18, 2026	3.03	3.15	2.97	3.08	170.06K
Feb 17, 2026	3.17	3.19	3.03	3.05	132.8K
Feb 13, 2026	2.94	3.23	2.94	3.18	186.83K
Feb 12, 2026	3.00	3.16	2.88	2.93	261.24K
Feb 11, 2026	2.82	2.99	2.61	2.97	357.17K
Feb 10, 2026	2.91	3.02	2.80	2.82	196.19K
Feb 09, 2026	2.88	3.02	2.83	2.94	319.89K
Feb 06, 2026	3.00	3.02	2.88	2.88	150.67K
Feb 05, 2026	3.07	3.07	2.94	2.98	164.45K
Feb 04, 2026	3.13	3.15	3.07	3.09	100.29K
Feb 03, 2026	3.06	3.13	3.02	3.13	97.62K
Feb 02, 2026	3.18	3.19	3.02	3.07	179.93K
Jan 30, 2026	3.20	3.22	3.14	3.19	90.63K
Jan 29, 2026	3.30	3.30	3.16	3.23	92.37K

Contact Details

Delray Beach, FL 33445

United States

https://www.1800petmeds.com 561 526 4444

About Company

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.

Stock Peers

ONC

-29.86-8.48%

BeOne Medicines Ltd.$322.37 HROWM

-0.02-0.08%

Harrow Health, Inc. 11.875% Senior Notes due 2027$26.03 HROWL

0.0478+0.19%

Harrow Health, Inc. 8.625% Senior Notes due 2026$25.61 LFMDP

0.115+0.51%

LifeMD, Inc.$22.79 DFTX

-0.33-1.87%

Definium Therapeutics, Inc.$17.29 CGEM

0.85+5.92%

Cullinan Therapeutics, Inc.$15.21 WBA

0.06+0.50%

Walgreens Boots Alliance, Inc.$11.98 MSLE

0.03+0.26%

Satellos Bioscience Inc. Common Stock$11.66 YI

-0.21-2.53%

111, Inc.$8.08 MEDS

0.33+4.55%

TRxADE HEALTH, Inc.$7.59

Company Overview

PetMed Express, Inc. (NASDAQ:PETS) closed at $2.75 USD, losing -$0.03 (-1.08%) from the previous close of $2.78. The stock is currently mid-range between its 52-week high and low $1.57 and $4.46. With a market capitalization of about $58.85 million, PetMed Express, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.72). Key stats such as the average daily volume over the past year has been around 2.70 million shares, volume is running light vs its 52-week average. Headquartered in Delray Beach, FL, PetMed Express, Inc. operates in the Healthcare sector and the Medical - Pharmaceuticals industry. Led by CEO Leslie C. G. Campbell, the company employs approximately 287 people and listed since April 26, 1999. PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States.

Technical Performance

Short-term trend indicators are mixed aligned (SMA20 -7.9%, SMA50 -14.93%, SMA200 -8.99%). The stock’s 14-day RSI is 37.57 (weak momentum), while the ATR of 0.16 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -39.29% below its high and over 75.16% above its low. Average 10-day trading volume of 97.57 thousand shares is below the 3-month average of 2.67 million, indicating normal recent market interest.

Valuation Metrics

PetMed Express, Inc. trades at a P/E ratio of -0.9, slightly below the S&P 500 average, with a price-to-sales ratio of 0.32 and a price-to-book ratio of 1.77 suggesting the stock is closer to book value. The P/FCF stands at -2.58, also above market averages.

Dividend & Fair Value

PetMed Express, Inc. last paid a dividend of 0 per share, this equals a trailing yield of roughly 22.22%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $34.40. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

The latest quarter delivered EPS of -$0.34. The next quarter is forecast at $nan. Next year's EPS is expected at $514.29. PetMed Express, Inc. earnings surprise history is frequent misses against expectations. The quarter that ended December 19, 2025, missed forecasts by 1600.0%. The prior quarter beat by -1500.0%. Over the last six quarters, Apple has recorded several small beats. These include -322.2% in November 06, 2024.

Shareholding & Insider Activity

PetMed Express, Inc. has 20.66 million shares outstanding. The public float is 13.73 million shares, elevated short interest at 9.48% of float. This equals 1.95 million shares. The short ratio is 14.29 days. Institutional investors hold 54.84% of the float. Insiders own 30.81%. Silvercape Investments Ltd holds 2.58 million shares, NINA CAPITAL HOLDINGS INC. has 2.58 million shares and Hulett Mathew N has 613.85 thousand shares.

Financial & Profitability Overview

Over the trailing twelve months, PetMed Express generated $226.97M in revenue, or $11.02 per share. Gross margin was 30.46%, operating margin -0.67%, and net profit margin -2.76%. Returns are negative, with ROA at -4.22% and ROE at -7.37%.
On valuation metrics, PetMed Express trades at a P/E of -0.90, P/S of 0.32 and P/B of 1.77. Liquidity is tight, with a current ratio of 0.89 and quick ratio of 0.66. Operationally, the company’s inventory turnover is 10.63 and cash conversion cycle is -19.66 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 0.02, supported by a cash flow-to-debt ratio of -25.52.

Quarterly Financial Highlights

For the quarter ended Mar 31, 2025, PetMed Express posted revenue of $226.97M, down slightly from $281.06M in the prior quarter. Gross profit was $69.14M (margin 30.46%). Operating income was - $1.53M (margin -0.7%). Net income was- $6.27M (EPS - $0.30).
The company ended the quarter with $54.72M in cash and short-term investments, a total debt of $996.00K, and net debt of - $53.72M. Total assets were $148.70M, with equity of $85.13M. Financials further reflected stability, with operating cash flow of $4.72M, free cash flow of - $395.00K, and capital expenditures of - $5.11M.

Price Forecast & Outlook

Our AI price prediction model suggests that PetMed Express, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -6.55%, with price expected at $2.57 by March 12, 2026, within a range of $2.46 to $2.69 3-Month Outlook: Projected rise of 254.55%, reaching $9.75 by May 27, 2026, with a range of $9.19 to $10.49. 1-Year Outlook: Projected gain of 10.91%, with price at $3.05 by February 26, 2027, within a range of $0.29 to $2.59.

Key Takeaways

PetMed Express, Inc. (NASDAQ:PETS) shares are flat 2.81% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows PetMed Express, Inc. trading at a premium to the broader market with a P/E of -0.9. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $23.21, suggesting 744.0% upside. Our AI forecast model points to short-term weakness (-6.55% over two weeks), a medium-term rise (254.55% over three months), and a longer-term gain (10.91% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current PetMed Express, Inc. (PETS) stock price?

PetMed Express, Inc. (NASDAQ: PETS) stock price is $2.75 in the last trading session. During the trading session, PETS stock reached the peak price of $2.78 while $2.71 was the lowest point it dropped to. The percentage change in PETS stock occurred in the recent session was -1.08% while the dollar amount for the price change in PETS stock was - $0.03.

PETS's industry and sector of operation?

The NASDAQ listed PETS is part of Medical - Pharmaceuticals industry that operates in the broader Healthcare sector. PetMed Express, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of PETS?

Wendy Zalai
Corporation Controller & Corp. Sec.
Mr. Daniel Job Pingree
Chief Marketing Officer
Ms. Jacqueline Smith
Vice President of People
Mr. Matthew N. Hulett
Chief Executive Officer, Pres & Director
Mr. Bruce S. Rosenbloom
Treasurer
Ms. Christine Chambers
Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer, Treasurer & Sec.
Mr. Mark Moseley
Chief Technology & Information Officer
Mr. Mathew N. Hulett
Chief Executive Officer, Pres & Director

How PETS did perform over past 52-week?

PETS's closing price is 75.16% higher than its 52-week low of $1.57 where as its distance from 52-week high of $4.46 is -39.02%.

How many employees does PETS have?

Number of PETS employees currently stands at 287.

Link for PETS official website?

Official Website of PETS is: https://www.1800petmeds.com

How do I contact PETS?

PETS could be contacted at phone 561 526 4444 and can also be accessed through its website. PETS operates from 420 South Congress Avenue, Delray Beach, FL 33445, United States.

How many shares of PETS are traded daily?

PETS stock volume for the day was 55.7K shares. The average number of PETS shares traded daily for last 3 months was 2.7M.

What is the market cap of PETS currently?

The market value of PETS currently stands at $58.85M with its latest stock price at $2.75 and 21.4M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	287
Beta	0.72
Sales or Revenue	$226.97M
5Y Sales Change%	-0.223%
Fiscal Year Ends	March
Sector	Healthcare
Industry	Medical - Pharmaceuticals

PETS Company Profile and Key Details

PetMed Express

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook